Dopa-sensibilité et Dopa-résistance : autant de réponses que de symptômes

Nonnekes, 2016, Unmasking levodopa resistance in Parkinson's disease, Mov Disord., 31, 1602, 10.1002/mds.26712 Kurlan, 2005, Levodopa phobia”: a new iatrogenic cause of disability in Parkinson disease, Neurology., 64, 923, 10.1212/01.WNL.0000152880.77812.5B Curtze, 2015, Levodopa is a double-edged sword for balance and gait in people with Parkinson's disease, Mov Disord., 30, 1361, 10.1002/mds.26269 Nonnekes, 2015, Freezing of gait: a practical approach to management, Lancet Neurol., 14, 768, 10.1016/S1474-4422(15)00041-1 Espay, 2012, On” state freezing of gait in Parkinson disease: a paradoxical levodopa-induced complication, Neurology., 78, 454, 10.1212/WNL.0b013e3182477ec0 Devos, 2009, Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease, Mov Disord., 24, 993, 10.1002/mds.22450 Chang, 2015, 24h Levodopa-carbidopa intestinal gel may reduce falls and “unresponsive” freezing of gait in Parkinson's disease, Parkinsonism Relat Disord., 21, 317, 10.1016/j.parkreldis.2014.12.019 Pezzoli, 2010, Levodopa in Parkinson's disease: from the past to the future, Expert Opin Pharmacother., 11, 627, 10.1517/14656561003598919 Barone, 2016, Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment, Lancet Neurol., 15, 1063, 10.1016/S1474-4422(16)30173-9 Caligiuri, 1993, Worsening of postural tremor in patients with levodopa-induced dyskinesia: a quantitative analysis, Clin Neuropharmacol., 16, 244, 10.1097/00002826-199306000-00008 Winogrodzka, 2001, Rigidity decreases resting tremor intensity in Parkinson's disease: A [(123)I]beta-CIT SPECT study in early, nonmedicated patients, Mov Disord., 16, 1033, 10.1002/mds.1205 Doder, 2003, 11C-WAY 100635 PET study. Tremor in Parkinson's disease and serotonergic dysfunction: an 11C-WAY 100635 PET study, Neurology, 60, 601, 10.1212/01.WNL.0000031424.51127.2B Isaias, 2012, A role for locus coeruleus in Parkinson tremor, Front Hum Neurosci, 5, 179, 10.3389/fnhum.2011.00179 Pirker, 2003, Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it?, Mov Disord, 18, S43, 10.1002/mds.10579 Benamer, 2003, Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations, Mov Disord., 18, 977, 10.1002/mds.10482 Fishman, 2008, Paradoxical aspects of parkinsonian tremor, Mov Disord., 23, 168, 10.1002/mds.21736 Schrag, 2002, Ropinirole for the treatment of tremor in early Parkinson's disease, Eur J Neurol., 9, 253, 10.1046/j.1468-1331.2002.00392.x Pogarell, 2002, Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study, J Neurol Neurosurg Psychiatry., 72, 713, 10.1136/jnnp.72.6.713 Kehagia, 2010, Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease, Lancet Neurol., 9, 1200, 10.1016/S1474-4422(10)70212-X Vorovenci, 2016, Therapy-resistant symptoms in Parkinson's disease, J Neural Transm (Vienna)., 123, 19, 10.1007/s00702-015-1463-8